H.C. Wainwright analyst Kevin Dede reiterated a Neutral rating on Biotricity (NASDAQ: BTCY).The analyst commented: "After the market close on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE